FDA/CDC

2021 ACIP adult schedule released


 

Vaccination in the pandemic

The updated schedule outlines guidance on the use of COVID-19 vaccines approved by the Food and Drug Administration under emergency use authorization, with interim recommendations for the Pfizer-BioNTech COVID-19 vaccine for people aged 16 and older and the Moderna COVID-19 vaccine for people aged 18 and older.

The authors stress the importance of receiving the recommended routine and catch-up immunizations notwithstanding widespread anxiety about visiting medical offices. Last spring, the CDC reported a dramatic drop in child vaccinations after the declaration of the national emergency in mid-March, a drop attributed to fear of COVID-19 exposure.

“ACIP continued to meet and make recommendations during the pandemic,” Dr. Freedman said. “Our recommendation remains that despite challenges caused by the COVID-19 pandemic, adults and their healthcare providers should follow the recommended vaccine schedule to protect against serious and sometimes deadly diseases.”

Regular vaccines can be safely administered even as COVID-19 retains its grasp on the United States. “Healthcare providers should follow the CDC’s interim guidance for the safe delivery of vaccines during the pandemic, which includes the use of personal protective equipment and physical distancing,” Dr. Freedman said.

Dr. Freedman has disclosed no relevant financial relationships. Coauthor Henry Bernstein, DO, is the editor of the Current Opinion in Pediatrics Office Pediatrics Series, is a Harvard School of Public Health faculty member, and is a member of the data safety and monitoring board for a Takeda study on intrathecal enzymes for Hunter and San Filippo syndromes. Coauthor Kevin Ault, MD, has served on the data safety and monitoring committee for ACI Clinical.

A version of this article first appeared on Medscape.com .

Pages

Recommended Reading

COVID-19: Another study links colchicine to better results
MDedge Cardiology
Rheumatologic disease activity an important influencer of COVID-19 death risk
MDedge Cardiology
Rollout of COVID-19 monoclonal antibodies lacked unified plan: expert panel
MDedge Cardiology
FDA curbs use of COVID-19 convalescent plasma, citing new data
MDedge Cardiology
U.K. COVID-19 variant doubling every 10 days in the U.S.: Study
MDedge Cardiology
Teenagers get in the queue for COVID-19 vaccines
MDedge Cardiology
COVID-19: Peginterferon lambda may prevent clinical deterioration, shorten viral shedding
MDedge Cardiology
Study: COVID cases have been ‘severely undercounted’
MDedge Cardiology
ColCORONA: More questions than answers for colchicine in COVID-19
MDedge Cardiology
PPE protected critical care staff from COVID-19 transmission
MDedge Cardiology